Targeting RAS

🎬 #TargetingRAS2025 comes to an end!

Three inspiring days of talks, round tables, and networking around the latest advances and challenges in RAS research. 🧬💡

A big thank you to all attendees, speakers, sponsors, partners, and the organizing committee for making this 2nd edition possible. 💙

🗣️ Julian Downward, Direna Alonso and Esther Castellano opened Day 3 of #TargetingRAS2025 by contributing with their lectures to Session 9: "Tumour Microenvironment".

☕ After Coffee Break, we continue with more innovative presentations by professionals.

🌅 The 3rd and final day of #TargetingRAS2025 begins!

Today’s program features Sessions 9, 10, and 11, closing this year’s symposium with a Closing Lecture by Dr. Frank McCormick. 🧬

It’s been an inspiring journey so far — let’s make this final day one to remember! ✨

🎥 Day 2 of #TargetingRAS2025 comes to an end!

A day filled with great talks, round tables, and outstanding speakers sharing insights on RAS research. 🧬💡

✨ Tonight: the Symposium Dinner.

👉 Tomorrow: the final day of the symposium.

🌇 The afternoon continues at #TargetingRAS2025 with Sessions 7 and 8.

🧬 This morning, we had the honor of hearing from Dr. Kevan Shokat, who delivered an outstanding lecture on “Targeting K-Ras Using Mutant Selective Covalent Chemistry.”

Francesco Passiglia, Kevan Shokat and Kristen McAulay have also given their presentation at Targeting RAS.

🗣️ The second day of #TargetingRAS2025 continues at the Palacio de Congresos of Salamanca after the Coffee Break! ☕

🌅 Day 2 of #TargetingRAS2025 begins!

Starting with Session 5, today brings exceptional speakers exploring new approaches, challenges, and innovations in RAS research.

Ready for another day of scientific exchange and collaboration. 🧬

@matthiasdrosten.bsky.social
@molinaarcas.bsky.social
@drcolinlindsay.bsky.social
@worldwidecancer.bsky.social
@crick.ac.uk
@crukpolicy.bsky.social
@sebbm.bsky.social
@aseica.bsky.social
@helloeacr.bsky.social
@csic.es
@ciccancer.bsky.social

🎥 Day 1 of #TargetingRAS2025 wrapped up!

An inspiring start with outstanding talks, great discussions, and valuable scientific exchange on RAS research.
Huge thanks to all speakers, attendees & organizers for a successful first day.

✨ Two more days to go—stay tuned!

The afternoon continues at #TargetingRAS2025 with international presentations during Session 3. 🌍

We conclude with the round table discussion in Session 4: "Building a Collaborative European Strategy on RAS." 🧬🤝🏽

The first day of #TargetingRAS2025 continues.

🍽️ Following the lunch break, the program resumes with Sessions 3 and 4, featuring cutting-edge research and discussions on the latest advances in RAS signaling and oncology. 🧬

🍽️ Lunch & Poster Session break!

We’ll pause the scientific sessions until 15:00 h — take this time to grab lunch, explore the posters, and connect with fellow attendees.

See you back soon for the afternoon talks! 🗣️

We don't want to forget all those who make the Targeting Ras symposium possible.

Thank you all 💙

🤲🏽Once again, a huge thank you to our sponsors for making the 2nd edition of #TargetingRAS2025 possible!

Your support drives research, collaboration, and innovation in the RAS field.

🎉 #TargetingRAS2025 has begun!

@xrbustelo.bsky.social , president of @ciccancer.bsky.social, welcomed attendees and opened the second edition of the symposium.

🧠 Session 1, RAS Signaling, kicks off three days of science and discovery in Salamanca.

El @ciccancer.bsky.social ( @usaloficial.bsky.social - @csic.es) recibe (8-10 octubre) a los expertos mundiales en nuevas terapias relacionadas con los oncogenes más resistentes

www.cicancer.org/press-room/c...

@matthiasdrosten.bsky.social
@molinaarcas.bsky.social
@drcolinlindsay.bsky.social
@worldwidecancer.bsky.social
@crick.ac.uk
@crukpolicy.bsky.social
@sebbm.bsky.social
@aseica.bsky.social
@helloeacr.bsky.social
@csic.es
@ciccancer.bsky.social

✨ CIC Salamanca
✨ Universidad de Salamanca
✨ CSIC
✨ Junta de Castilla y León 
✨ Fundación Científica de la Asociación Española Contra el Cáncer 
✨ Ayuntamiento de Salamanca 
✨ CeGaT
✨ MedChemExpress
✨ BridgeBio Oncology Therapeutics
✨ Molecular Oncology

We are proud to count on the support of our sponsors, who make #TargetingRAS2025 possible.

Your commitment to advancing RAS research is invaluable. Thank you for joining us on this journey to accelerate discoveries and foster collaboration.

#25anniversaryCIC #Sponsors

@matthiasdrosten.bsky.social
@molinaarcas.bsky.social
@drcolinlindsay.bsky.social
@worldwidecancer.bsky.social
@crick.ac.uk
@crukpolicy.bsky.social
@sebbm.bsky.social
@aseica.bsky.social
@helloeacr.bsky.social
@csic.es
@ciccancer.bsky.social

📌 Poster Presentations at #TargetingRAS2025

From Oct 8–10 in Salamanca:
✅ Explore innovative RAS research
✅ Connect with presenters worldwide
✅ Support the next generation of scientists

💡 Posters aren’t just displays — they’re conversation starters. Don’t miss them!

@matthiasdrosten.bsky.social
@molinaarcas.bsky.social
@drcolinlindsay.bsky.social
@worldwidecancer.bsky.social
@crick.ac.uk
@crukpolicy.bsky.social
@sebbm.bsky.social
@aseica.bsky.social
@helloeacr.bsky.social
@csic.es
@ciccancer.bsky.social

⏳ The countdown is on: 2 weeks to go!

In just 14 days, Salamanca will host #TargetingRAS2025, a symposium uniting researchers and industry leaders to push the boundaries of RAS biology.

💡 Have you checked your registration and planned your trip? We can’t wait to welcome you!

#25anniversaryCIC

@matthiasdrosten.bsky.social
@molinaarcas.bsky.social
@drcolinlindsay.bsky.social
@worldwidecancer.bsky.social
@crick.ac.uk
@crukpolicy.bsky.social
@sebbm.bsky.social
@aseica.bsky.social
@helloeacr.bsky.social
@csic.es
@ciccancer.bsky.social

🔍 What to expect at #TargetingRAS2025?

From Oct 8–10, Salamanca will unite world-class scientists, young researchers & industry leaders to explore the latest in RAS biology.

✨ Highlights: Keynotes, KRAS sessions, posters, Short Talks & networking.

📅 Get ready for 3 days of cutting-edge science!

📖 Explore the selected talks and don’t miss the opportunity to engage with new ideas and perspectives during the sessions in Salamanca.